https://www.selleckchem.com/pr....oducts/ulonivirine.h
People living with HIV (PLWH) are commonly coinfected with Mycobacterium tuberculosis, particularly in high-transmission resource-limited regions. Despite expanded access to antiretroviral therapy and tuberculosis (T treatment, TB remains the leading cause of death among PLWH. This review discusses recent advances in the management of TB in PLWH and examines emerging therapeutic approaches to improve outcomes of HIV-associated TB. Three recent key developments have transformed the management of HIV-associated TB. First, the scalin
Curtir
Comentario
Compartilhar
